Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Biotechnology Pharmaceutical Health Care
Funding Amount: $95M
Funding Type: Series D
Funding Date: 2022-08-11
City & State: Hong Kong, Hong Kong Island
Country Hong Kong
Employee Count: 176
Similar Startups
Synthpop
Synthpop is streamlining healthcare, one workflow at a time. Synthpop’s AI agents perform complex healthcare administrative tasks - from fax wrangling and referral processing, to quickly validating medical orders against payor and clinical guidelines.
Sensi.AI
Sensi.Ai developed the first audio AI that's able to analyze the routine in long term care environments, detect anomalies and provide insight on trends, with the purpose of improving the quality of care.
Jogo Health
Jogo Health comprises an AI driven mobile app and wearable sensors to to treat chronic pain, migraine, stroke, pelvic floor and movement disorders using the foundational science of EMG Biofeedback.
Marigold Health
Marigold Health uses AI-augmented chat support groups to reach and retain patients with behavioral health needs in community-based treatment. Patients receive a personalized wraparound support while care teams see dramatic gains in capacity using patients to engage each other.